Download Sample
Schedule a Meeting
NA : +1 804 441 9344
sales@towardshealthcare.com
September 2025
The global 3D ultrasound market size is calculated at US$ 4.29 billion in 2024, grew to US$ 4.74 billion in 2025, and is projected to reach around US$ 11.55 billion by 2034. The market is expanding at a CAGR of 10.44% between 2025 and 2034.
The use of 3D ultrasound devices is increasing for diagnosing various conditions as well as diseases. There is a rise in the funding provided by the companies to accelerate their development. Additionally, AI is also being used to enhance its accuracy and image quality. The growing adoption of portable ultrasound devices, along with their growing use during maternal care, is increasing their acceptance rates in various regions. The companies are collaborating and launching their new 3D ultrasound devices as well. Thus, this is enhancing the market growth.
| Table | Scope |
| Market Size in 2025 | USD 4.74 Billion |
| Projected Market Size in 2034 | USD 11.55 Billion |
| CAGR (2025 - 2034) | 10.44% |
| Leading Region | North America 39% |
| Market Segmentation | By Product Type, By Technology, By Application, By End User, By Region |
| Top Key Players | GE HealthCare , Siemens Healthineers , Philips Healthcare , Canon Medical Systems Corporation, Samsung Medison, FUJIFILM Sonosite, Esaote S.p.A., Hitachi Healthcare, Mindray Medical International, Clarius Mobile Health, Butterfly Network, Inc., Terason Ultrasound, ContextVision AB, TomTec Imaging Systems GmbH, CHISON Medical Technologies, Konica Minolta Healthcare, Analogic Corporation, Supersonic Imagine (Hologic), Carestream Health, Telemed Ultrasound |
The 3D Ultrasound Market includes advanced imaging systems that generate three-dimensional representations of internal body structures using ultrasound waves. Unlike conventional 2D ultrasound, 3D ultrasound provides detailed volumetric images, enabling improved visualization of organs, tissues, blood flow, and fetal development. It is widely used in obstetrics & gynecology, cardiology, oncology, urology, and musculoskeletal applications. Market growth is fueled by rising demand for early disease detection, growing use in minimally invasive procedures, technological advancements (AI integration, real-time 4D imaging), and expanding applications in both clinical and research settings.
Increasing advancements: As the applications of 3D ultrasound are increasing, there is a rise in their innovations. These innovations are focusing on enhancing their image resolution, portability, and real-time imaging. These advancements are being supported by the funding provided by various companies.
For instance,
The medical imaging, diagnostic accuracy, and clinical workflows are being transformed by integrating AI in 3D ultrasound devices. The image quality, disease diagnosis, as well as quality assessments can be improved with the use of AI algorithms. It also helps in providing intelligent diagnostic assistance, medical education, as well as can conduct automated image analysis. This, in turn, is increasing their use in the precise detection of lesions in various organs. Additionally, it can enhance the diagnostic accuracy as AI can detect the errors.
Increasing Demand for Accurate Diagnostic Imaging
For early and accurate detection of growing diseases, the demand for accurate diagnostic imaging is increasing. This is increasing the use of 3D ultrasound as it provides better imaging along with enhanced accuracy. It helps in detecting abnormalities present in an organ or tissue. This is increasing their use in the diagnosis of cardiac defects, cysts, or tumors. They are also being used in monitoring fetal development. Moreover, their non-invasive and radiation-free approach is increasing their use. Thus, this drives the 3D ultrasound market growth.
Higher Equipment Cost
The 3D ultrasound devices are expensive compared to the 2D ultrasound devices. Additionally, their regular software updates and maintenance are costly. This limits their adoption in hospitals with limited infrastructure or in small clinics. Moreover, a lack of proper reimbursement policies can decrease their use by the patients.
Why the Growth in the Use of Portable Ultrasound Devices is an Opportunity in the 3D Ultrasound Market?
There is a rise in the use of portable ultrasound devices due to their growing point-of-care applications. They are being used for home testing, remote diagnostics, as well as during emergency conditions. These help in providing faster imaging as well as increasing their accessibility in remote areas. This, in turn, is increasing their integration with telemedicine for image sharing and remote consultations. Moreover, they are user-friendly, which is also increasing their use. Innovations are also being made to improve their imaging quality and real-time analysis. Thus, this is promoting the 3D ultrasound market growth.
For instance,
By product type, the cart/trolley-based ultrasound systems segment held the largest share of approximately 47% in the market in 2024, due to its high-quality imaging. This, in turn, increased their use in obstetric and gynecology departments. Additionally, it also offered advanced features that contributed to their increased use in hospitals.
By product type, the portable/handheld ultrasound devices segment is expected to show the fastest growth rate during the predicted time. They are being used for point-of-care applications in various settings. It also provides enhanced imaging quality. Moreover, they are affordable and can be used for remote diagnostics.
By technology type, the Doppler ultrasound segment led the market with approximately a 38% share in 2024, as it provides 3D imaging and real-time analysis of blood flow. This enhanced the diagnostic accuracy. This, in turn, increased their use in various fields such as cardiology, radiology, obstetrics, etc.
By technology type, the 4D/real-time 3D ultrasound segment is expected to show the highest growth during the predicted time. They were used in real-time visualizations for organ function or fetal movements. They are also being used for the detection of abnormalities. Furthermore, their use in musculoskeletal or cardiology is also increasing.
By application type, the obstetrics & gynecology segment held the dominating share of approximately 42% share in the market in 2024, as 3D ultrasound devices were used for detecting fetal development or its abnormalities. It was also used for diagnosing the uterus, pelvic organs, or ovaries. Additionally, due to their non-invasive approach, their use in pregnancy increased.
By application type, the cardiology segment is expected to show the fastest growth rate during the upcoming years. The 3D ultrasound devices are being used in echocardiography & heart failure monitoring. This, in turn, is providing early detection of cardiovascular diseases with improved accuracy.
By end user, the hospitals segment led the global market with approximately 50% share in 2024, due to the large volume of patients. The hospitals also consisted of various departments, which increased their use. They were also used during daily practices as well as in emergency cases.
By end user, the diagnostic imaging centers segment is expected to show the highest growth during the upcoming years. The rising outpatient diagnostic volumes are increasing their acceptance rates. They are also providing advanced 3D ultrasound devices. Moreover, their affordable services are attracting patients.
North America dominated the 3D ultrasound market share 39% in 2024. North America consisted of well well-developed healthcare sector, which increased the use of 3D ultrasound. They were increasingly utilized in OB/GYN and cardiology hospitals and clinics. Additionally, the reimbursement policies increased their use. Thus, this contributed to the market growth.
The presence of advanced healthcare infrastructure in the U.S. is increasing the use of advanced 3D ultrasound devices. They are being used to provide the patients with improved diagnosis due to their better resolution and real-time monitoring. They are mostly used in the OB/GYN and cardiology departments. Portable 3D ultrasound devices are also being utilized by the clinics.
The 3D as well as 4D ultrasound devices are being adopted by the healthcare sector of Canada. Moreover, funding is also being provided to increase their access. Additionally, due to their safe and improved imaging, they are being used in the OB/GYN and radiology departments. Furthermore, the use of handheld 3D devices is also increasing to promote remote diagnostics.
Asia Pacific is expected to host the fastest-growing 3D ultrasound market during the forecast period. The healthcare infrastructure of the Asia Pacific is expanding, which is increasing the adoption of advanced technologies such as 3D ultrasound devices. The rising maternal care demand, as well as growing diseases, are increasing their use. Additionally, the adoption of portable ultrasound systems is increasing for point-of-care applications. Investments are also provided by the government and the private sector to increase their access and development. Thus, this is promoting the market growth.
The enhancements of imaging quality, speed, and affordability with the use of hardware such as transducer arrays and software integrated with AI are the main focus of the R&D of 3D ultrasound devices.
Key Players: Philips Healthcare, GE HealthCare, Samsung Medison, Siemens Healthineers, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Canon Medical Systems Corporation.
Evaluation of the clinical superiority of 3D ultrasound over 2D imaging for its specific application and validation of AI features are the focus of the clinical trials, while the risk and novelty are tested in the regulatory approvals for 3D ultrasound devices.
Key Players: Philips Healthcare, GE HealthCare, Samsung Medison, Siemens Healthineers, Ltd., Canon Medical Systems Corporation, PIUR IMAGING, EXO.
The packaging and serialization of 3D ultrasound focuses on protecting the device integrity and sterility, along with anticounterfeiting measures and strong supply chain traceability with the use of a unique device identifier (UDI).
Key Players: Philips Healthcare, GE HealthCare, Siemens Healthineers, Ltd., DuPont, Amcor.
The direct sales from major manufacturers or by specialized medical device distributors, managing logistics, are responsible for the distribution of 3D ultrasound devices to hospitals.
Key Players: Philips Healthcare, GE HealthCare, Siemens Healthineers, Ltd., Canon Medical Systems Corporation.
The patient support and services for 3D ultrasound devices focus on educating patients, providing comfortable and clear procedures, increasing diagnostic information access, and improving the patient and provider bonding experience.
Key Players: Philips Healthcare, GE HealthCare, and Magnus Diagnostic Centre.
In May 2025, after announcing the collaboration between Exo Imaging and Samsung Medison for developing advanced ultrasound solutions, the CEO of Samsung Medison, Dr. Kyu Tae Yoo, commented that a major step forward in transforming ultrasound imaging will be taken with this collaboration. Moreover, to improve the clinical experience for practitioners and patients and to enhance the diagnostic capabilities, they will be delivering new innovations.
By Product Type
By Technology
By Application
By End User
By Region
September 2025
September 2025
September 2025
September 2025